Comprehensive literature review about drug shortages in the canadian hospital's pharmacy supply chain

TA Zwaida, Y Beauregard… - … on Engineering, Science …, 2019 - ieeexplore.ieee.org
Pharmacies play a central role between the manufacturers and patients because they
ensure that patients access their required medications. In health facilities, pharmacies …

Medicine shortages in Australia: causes, impact and management strategies in the community setting

YX Tan, RJ Moles, BB Chaar - International journal of clinical pharmacy, 2016 - Springer
Background Medicine shortages are an ongoing global problem. The Therapeutic Goods
Administration (TGA) dedicated a website for monitoring of medicine shortages in Australia …

Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016

MA Gagnon, KD Volesky - Globalization and health, 2017 - Springer
Background Drug shortages and increasing generic drug prices are associated with low
levels of competition. Mergers and acquisitions impact the level of competition. Record …

Factors associated with drug shortages in Canada: a retrospective cohort study

W Zhang, DP Guh, H Sun, LD Lynd, A Hollis… - … Open Access Journal, 2020 - cmajopen.ca
Background: To monitor the magnitude of the drug shortage problem in Canada, since 2017,
Health Canada has required manufacturers to report drug shortages. This study aimed to …

Effects and determinants of tuberculosis drug stockouts in South Africa

LEM Koomen, R Burger, EKA Van Doorslaer - BMC health services …, 2019 - Springer
Background The frequent occurrence of medicine stockouts represents a significant obstacle
to tuberculosis control in South Africa. Stockouts can lead to treatment alterations or …

[图书][B] A roadmap to a rational pharmacare policy in Canada

MA Gagnon - 2014 - nursesunions.ca
2010. Based on conservative hypotheses, the report showed that a public and universal
drug plan based on first-dollar coverage would not only improve access to prescription …

The road to competitive generic drug prices in Canada

MR Law, J Kratzer - Cmaj, 2013 - Can Med Assoc
© 2013 Canadian Medical Association or its licensors CMAJ, September 17, 2013, 185 (13)
1141 overpay for generic drugs that 1 or more manufacturers would have been willing to sell …

Generic but expensive: why prices can remain high for off-patent drugs

FA Tessema, AS Kesselheim, MA Sinha - Hastings LJ, 2019 - HeinOnline
Brand-name prescription drugs are sold at extremely high prices in the United States
because patents and other market exclusivities provided by the government allow …

[HTML][HTML] A better prescription: advice for a national strategy on pharmaceutical policy in Canada

SG Morgan, MA Gagnon, B Mintzes, J Lexchin - Healthcare policy, 2016 - ncbi.nlm.nih.gov
Canada needs a national strategy to fulfill its obligation to ensure universal access to
necessary healthcare, including prescription drugs. A 2004 attempt at a national strategy for …

Determinants of the global prices of ready-to-use therapeutic foods

J Kakietek - Food and nutrition bulletin, 2018 - journals.sagepub.com
Background: A therapy based on ready-to-use therapeutic food (RUTF) in outpatient settings
is considered the gold standard in the treatment of severe acute malnutrition in children …